CareLit Fachartikel

Integration of Real-World Data into Clinical Trials: An Interdisciplinary Discussion from Regulatory and Practical Perspectives

Köppe, J.; Schiel, A.; Gerlinger, C.; Götte, H.; Edelmann, D.; Erdmann, S. · Das Gesundheitswesen · 2026 · Heft EFirst · S. 1 bis 1

Dokument
572405
CareLit-ID
Jahr
2026
Publikation
PDF
ja
Volltext
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Das Gesundheitswesen
Autor:innen
Köppe, J.; Schiel, A.; Gerlinger, C.; Götte, H.; Edelmann, D.; Erdmann, S.
Ausgabe
Heft EFirst / 2026
Jahrgang 88
Seiten
1 bis 1
Erschienen: 2026-02-23 13:00:00
ISSN
0941-3790

Zusammenfassung

Increasing efforts are required to integrate the growing volume of so-called real-world data (also named routine practice data), which are data generated outside of randomized controlled trials, into regulatory studies. Various stakeholders anticipate that such integration could save time and financial resources during the approval process of new therapies, and ethical considerations also partially support such an approach. The aim of this manuscript is to provide an overview of the methodological, ethical, and regulatory considerations when integrating routine practice data into randomized controlled trials. It…

Schlagworte

Bias Germany Lead Drug Development Population Biometrie After Association Big Data Movement Blood Work Arzneimittelentwicklung Administration Oral Drug Discovery